ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of a Low Advanced Glycation End Products (AGE) Diet in the Metabolic Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01363141
Recruitment Status : Completed
First Posted : June 1, 2011
Last Update Posted : May 8, 2015
Sponsor:
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
Icahn School of Medicine at Mount Sinai

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2014
  Actual Study Completion Date : December 2014
Publications:
4. Vlassara, H., Striker, G.E Advanced Glycation Endproducts in Diabetes - A Paradigm Shift", Nature-Endocrinology, 2011, in press.
6. Vlassara, H. and Striker, G.E. (2010) Intake of advanced glycation endproducts; Role in the development of diabetic complications. In: Principles of Diabetes Mellitus, 2nd Edition, L. Poretsky, Ed., Springer Publications.
7. Vlassara, H, Striker, G.E. The Role of AGEs in the Etiology of Insulin Resistance and Diabetes; US-Endocrinology (2011).

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):